UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2086-2092

2007

Volltextzugriff (PDF)

Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations

Cancer treatment reviews, 2013-06, Vol.39 (4), p.328-339

2013

Volltextzugriff (PDF)

Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients

Lung cancer (Amsterdam, Netherlands), 2014-12, Vol.86 (3), p.324-328

2014

Volltextzugriff (PDF)

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Journal of clinical oncology, 2005-05, Vol.23 (13), p.3125-3137

2005

Volltextzugriff (PDF)

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

Lung cancer (Amsterdam, Netherlands), 2010-06, Vol.68 (3), p.319-331

2010

Volltextzugriff (PDF)

Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-04, Vol.80 (1), p.35-38

2013

Volltextzugriff (PDF)

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

Anticancer research, 2008-01, Vol.28 (1B), p.507-513

2008

Volltextzugriff (PDF)

Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan

Lung cancer (Amsterdam, Netherlands), 2014-10, Vol.86 (1), p.91-95

2014

Volltextzugriff (PDF)

Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2014-02, Vol.83 (2), p.265-271

2014

Volltextzugriff (PDF)

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

Cancer, 2006-12, Vol.107 (12), p.2842-2849

2006

Volltextzugriff (PDF)

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin

Lung cancer (Amsterdam, Netherlands), 2012-10, Vol.78 (1), p.92-99

2012

Volltextzugriff (PDF)

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers

Lung cancer (Amsterdam, Netherlands), 2010-03, Vol.67 (3), p.355-360

2010

Volltextzugriff (PDF)

Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

Lung cancer (Amsterdam, Netherlands), 2012-06, Vol.76 (3), p.269-279

2012

Volltextzugriff (PDF)

Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report

Lung cancer (Amsterdam, Netherlands), 2009-08, Vol.65 (2), p.251-253

2009

Volltextzugriff (PDF)

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy

Lung cancer (Amsterdam, Netherlands), 2009-05, Vol.64 (2), p.199-206

2009

Volltextzugriff (PDF)

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational “SUN” (Survey on the lUng cancer maNagement) study

Lung cancer (Amsterdam, Netherlands), 2011-12, Vol.74 (3), p.462-468

2011

Volltextzugriff (PDF)

In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines

Oncology research, 2005, Vol.15 (1), p.39-48

2005

Volltextzugriff (PDF)

Update on the treatment of small cell lung cancer (SCLC)

Annals of oncology, 2000, Vol.11, p.101-108

2000

Volltextzugriff (PDF)

In vitro study of farnesyltransferase inhibitor SCH 66336, in combination with chemotherapy and radiation, in non-small cell lung cancer cell lines

Oncology reports, 2004-02, Vol.11 (2), p.407

2004

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaTumors

ThemaTumors Of The Respiratory System And Mediastinum

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(21)
Humans
(21)
Life Sciences & Biomedicine
(21)
Medical Sciences
(21)
Oncology
(21)
Pneumology
(21)
Science & Technology
(21)
Lung Neoplasms - Drug Therapy
(14)
Aged
(13)
Male
(13)
Female
(12)
Hematology, Oncology And Palliative Medicine
(12)
Lung Neoplasms - Pathology
(12)
Middle Aged
(12)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(11)
Pulmonary/respiratory
(11)
Respiratory System
(11)
Adult
(9)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer

Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations

Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan

Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC)

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers

Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational “SUN” (Survey on the lUng cancer maNagement) study

In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines

Update on the treatment of small cell lung cancer (SCLC)

In vitro study of farnesyltransferase inhibitor SCH 66336, in combination with chemotherapy and radiation, in non-small cell lung cancer cell lines

Aktive Filter

Suchergebnisse filtern